PARP1 and ischemic stroke: reported that gene disruption of PARP could abrogate glutamate–NO-mediated neurotoxicity in both cortical neurons and an MCAO rat model, suggesting that inhibition of PARP may provide a novel therapeutic strategy in ischemic stroke [133].